BlackRock Health Sciences Term Trust Announces $1.32 Annual Dividend Per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 06 2026
0mins
Source: NASDAQ.COM
- Dividend Appeal: BlackRock Health Sciences Term Trust offers an annual dividend of $1.32 per share, paid monthly, reflecting its stable cash flow and profitability, which attracts income-seeking investors.
- Investment Timing: The upcoming ex-dividend date is set for January 20, 2026, prompting investors to pay attention to this date to seize investment opportunities and ensure they purchase before the ex-date to qualify for the dividend.
- Historical Performance Analysis: The report emphasizes the importance of studying a company's past dividend history to assess the sustainability of the current dividend, providing investors with a basis for evaluating future performance.
- Value Investment Strategy: By utilizing a proprietary DividendRank formula, the report aims to identify companies with strong profitability and attractive valuations, assisting value investors in discovering high-quality stocks that merit further research.
Analyst Views on BMEZ
About BMEZ
BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, diversified financial services, health care technology, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
